A specific opiate antagonist that has no agonist activity. It is a competitive antagonist at mu, delta, and kappa opioid receptors.
More specific conditions that are subtypes of Naloxone in the MeSH hierarchy.
7 drugs approved
Phase 4 trials (1)
Phase 2 trials (1)
Other trials (1)